Works matching IS 00126667 AND DT 2022 AND VI 82 AND IP 3

Results: 12

Authors' Reply to Mazza et al.: "Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence".

Published in:

2022

By:

Lenze, Eric J.;
Reiersen, Angela M.;
Facente, Shelley N.

Publication type:

Letter to the Editor

Pharmacologic Management of Persistent Pain in Cancer Survivors.

Published in:

Drugs, 2022, v. 82, n. 3, p. 275, doi. 10.1007/s40265-022-01675-6

By:

Glare, Paul;
Aubrey, Karin;
Gulati, Amitabh;
Lee, Yi Ching;
Moryl, Natalie;
Overton, Sarah

Publication type:

Article

Efgartigimod: First Approval.

Published in:

Drugs, 2022, v. 82, n. 3, p. 341, doi. 10.1007/s40265-022-01678-3

By:

Heo, Young-A

Publication type:

Article

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.

Published in:

Drugs, 2022, v. 82, n. 3, p. 251, doi. 10.1007/s40265-021-01670-3

By:

Burnette, Elizabeth M.;
Nieto, Steven J.;
Grodin, Erica N.;
Meredith, Lindsay R.;
Hurley, Brian;
Miotto, Karen;
Gillis, Artha J.;
Ray, Lara A.

Publication type:

Article

Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence".

Published in:

2022

By:

Mazza, Mario Gennaro;
Vai, Benedetta;
De Picker, Livia;
Benedetti, Francesco;
Zanardi, Raffaella

Publication type:

Letter

Correction to: Ocular Toxicity of Targeted Anticancer Agents.

Published in:

2022

By:

Fortes, Blake H.;
Tailor, Prashant D.;
Dalvin, Lauren A.

Publication type:

Correction Notice

Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature.

Published in:

Drugs, 2022, v. 82, n. 3, p. 293, doi. 10.1007/s40265-021-01668-x

By:

Rendon, Luis F.;
Tewarie, Ishaan A.;
Cote, David J.;
Gabriel, Aaron;
Smith, Timothy R.;
Broekman, Marike L. D.;
Mekary, Rania A.

Publication type:

Article

Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future Directions.

Published in:

Drugs, 2022, v. 82, n. 3, p. 241, doi. 10.1007/s40265-021-01667-y

By:

Elgendy, Islam Y.;
Ya'Qoub, Lina;
Chen, Kuan-Han;
Pepine, Carl J.

Publication type:

Article

Maribavir: First Approval.

Published in:

Drugs, 2022, v. 82, n. 3, p. 335, doi. 10.1007/s40265-022-01677-4

By:

Kang, Connie

Publication type:

Article

Ocrelizumab: A Review in Multiple Sclerosis.

Published in:

Drugs, 2022, v. 82, n. 3, p. 323, doi. 10.1007/s40265-022-01672-9

By:

Lamb, Yvette N.

Publication type:

Article

Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases.

Published in:

Drugs, 2022, v. 82, n. 3, p. 311, doi. 10.1007/s40265-021-01665-0

By:

Li, Tian;
Providencia, Rui;
Jiang, Wenhua;
Liu, Manling;
Yu, Lu;
Gu, Chunhu;
Chang, Alex Chia Yu;
Ma, Heng

Publication type:

Article

Efgartigimod: First Approval.

Published in:

Drugs, 2022, v. 82, n. 3, p. 341, doi. 10.1007/s40265-022-01678-3

By:

Heo, Young-A

Publication type:

Article